CENTRIENT PHARMACEUTICALS NETHERLANDS BV

Overview

CENTRIENT PHARMACEUTICALS NETHERLANDS BV is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering AMOXICILLIN TRIHYDRATE (PURIMOX); AMOXICILLIN TRIHYDRATE (PURIMOX®); ATORVASTATIN CALCIUM; CEFADROXIL MONOHYDRATE USP (PURIDROX ®); CEPHALEXIN MONOHYDRATE; NYSTATIN.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances CENTRIENT PHARMACEUTICALS NETHERLANDS BV is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

CENTRIENT PHARMACEUTICALS NETHERLANDS BV holds 7 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ROSUVASTATIN CALCIUMActive2017-03-28
• ATORVASTATIN CALCIUMActive2015-08-03
• AMOXICILLIN TRIHYDRATE (PURIMOX)Active2012-03-16
• AMOXICILLIN TRIHYDRATE (PURIMOX®)Active2003-11-14
• CEFADROXIL MONOHYDRATE USP (PURIDROX ®)Active1998-09-01
• NYSTATINActive1998-09-01
• CEPHALEXIN MONOHYDRATEActive1998-04-30
• AMPICILLIN TRIHYDRATE (PURICILLIN)Inactive2012-10-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CENTRIENT PHARMACEUTICALS NETHERLANDS BV in our records. PharmaTek screens the full directory against live FDA enforcement data.